Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$44,770,847
+$1,585,877 QoQ
Shares Held
176,284
-0.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#468
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $225,886,114 across 15 Drug Manufacturers - General names. JNJ ranks #2 (19.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
78,924 | $94,663,821 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
176,284 | $44,770,847 | |
| 3 | ABBV |
AbbVie Inc.
|
132,322 | $33,297,508 | |
| 4 | MRK |
Merck & Co., Inc.
|
176,330 | $22,658,405 | |
| 5 | AMGN |
Amgen Inc
|
32,937 | $11,927,146 | |
| 6 | NVS |
Novartis AG
|
71,102 | $11,143,105 | |
| 7 | NVO |
Novo Nordisk A S
|
61,839 | $2,964,561 | |
| 8 | PFE |
Pfizer Inc
|
106,893 | $2,573,983 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,770,847 | 176,284 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $43,184,970 | 176,669 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $36,789,501 | 177,770 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $33,070,769 | 178,356 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $27,292,300 | 178,673 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $29,763,470 | 179,471 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $25,964,930 | 179,539 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $29,014,574 | 179,036 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $26,227,827 | 179,446 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $28,241,502 | 178,529 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $27,347,838 | 174,479 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $26,746,013 | 171,724 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $29,296,874 | 176,999 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $27,198,315 | 175,473 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $29,901,722 | 169,271 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $27,304,317 | 167,142 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $29,326,249 | 165,209 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $28,863,500 | 162,859 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $27,673,309 | 161,766 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $25,986,157 | 160,905 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $25,854,295 | 156,940 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $25,854,227 | 157,312 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $24,543,096 | 155,948 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $23,016,252 | 154,596 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $21,722,412 | 154,465 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $20,341,410 | 155,124 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||